Barclays raised the firm’s price target on Stryker (SYK) to $418 from $402 and keeps an Overweight rating on the shares. The company reported an impressive beat, driven by 11.5% organic growth, double-digit growth across most major businesses and upside to operating margins, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK: